EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 62 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,902,255 | -6.3% | 3,492,147 | +2.0% | 1.51% | -5.3% |
| Q2 2023 | $29,787,904 | +198.4% | 3,423,897 | +0.9% | 1.59% | +277.5% |
| Q1 2023 | $9,980,997 | -14.8% | 3,394,897 | +1.4% | 0.42% | -14.2% |
| Q4 2022 | $11,717,640 | -54.2% | 3,347,897 | +3.5% | 0.49% | -53.7% |
| Q3 2022 | $25,578,000 | +9.5% | 3,233,597 | +8.9% | 1.06% | +19.6% |
| Q2 2022 | $23,360,000 | -33.9% | 2,968,207 | +2.0% | 0.89% | -17.8% |
| Q1 2022 | $35,349,000 | +14.6% | 2,909,407 | +15.5% | 1.08% | +80.9% |
| Q4 2021 | $30,841,000 | +73.6% | 2,519,700 | +47.8% | 0.60% | +99.7% |
| Q3 2021 | $17,762,000 | +43.3% | 1,704,589 | +23.7% | 0.30% | +61.6% |
| Q2 2021 | $12,391,000 | +3.2% | 1,378,332 | +16.7% | 0.18% | +4.5% |
| Q1 2021 | $12,001,000 | – | 1,181,200 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,490,921 | $27,892,459 | 24.59% |
| ACUTA CAPITAL PARTNERS, LLC | 300,128 | $2,398,023 | 1.61% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,492,147 | $27,902,255 | 1.51% |
| Cormorant Asset Management, LP | 3,200,000 | $25,568,000 | 1.49% |
| Samsara BioCapital, LLC | 432,000 | $3,451,680 | 1.06% |
| Ghost Tree Capital, LLC | 325,000 | $2,596,750 | 0.85% |
| RA Capital Management | 3,370,506 | $26,930,343 | 0.53% |
| Ikarian Capital, LLC | 4,487 | $3,585,113 | 0.43% |
| Affinity Asset Advisors, LLC | 155,000 | $1,238,450 | 0.35% |
| SECTORAL ASSET MANAGEMENT INC | 176,080 | $1,406,879 | 0.27% |